Alpha Fusion
Latest round
- Series B
Last raised
- Oct 2024
Total raised
- $10M
Investors
- 9
About Alpha Fusion
Founded in 2021 and based in Osaka, Japan, Alpha Fusion Inc. operates as a radiopharmaceutical company that offers anticancer drugs. In March 2023, Alpha Fusion Inc. As of 2023, the company’s CEO is Sunao Fujioka. Alpha Fusion engages in the development and commercialization of astatine-based radiopharmaceuticals for the treatment of cancer. The company offers Astatine-211, which is an alpha-nuclear medicine treatment that targets targeted alpha therapy (TAT) cancer cells for the treatment of cancer.
Who invested in Alpha Fusion
9 investors across 2 rounds
See all investors in Alpha Fusion
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Alpha Fusion
Who invested in Alpha Fusion?
Alpha Fusion has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alpha Fusion raised?
Alpha Fusion has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Alpha Fusion last raise money?
Alpha Fusion's most recent round on record is a Series B, in Oct 2024.
What does Alpha Fusion do?
Founded in 2021 and based in Osaka, Japan, Alpha Fusion Inc.
Where is Alpha Fusion headquartered?
Alpha Fusion is headquartered in Osaka-shi, Japan.
Which VCs invest in companies like Alpha Fusion?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Alpha Fusion's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Alpha Fusion? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.